Context Therapeutics Inc. (CNTX) vs Rockwell Medical, Inc. (RMTI)
A side-by-side comparison of Context Therapeutics Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RMTI
Rockwell Medical, Inc.
$8.18HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Total return — CNTX vs RMTI
growth of $100 · dividends reinvested · last 5yCNTX -93.4% (-41.9%/yr)RMTI -87.3% (-33.8%/yr)RMTI compounded faster over this window
CNTX RMTI
CNTX vs RMTI: by the numbers
- •RMTI is the larger company ($32M vs $30M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -7.33% net margin).
Metrics side by side
Valuation
| Metric | CNTX | RMTI |
|---|---|---|
| P/S ratio | N/A | 0.47 |
| P/B ratio | 0.77 | 0.92 |
| FCF yield | N/A | 4.77% |
Profitability
| Metric | CNTX | RMTI |
|---|---|---|
| Gross margin | 0.00% | 17.71% |
| Operating margin | 0.00% | -6.52% |
| Net margin | 0.00% | -7.33% |
| ROE | -120.40% | -14.49% |
| ROIC | -126.84% | -9.60% |
Growth (annualized)
| Metric | CNTX | RMTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.59% |
| Total return CAGR (5Y) | N/A | -33.38% |
Go deeper
Dig into the metrics
Context Therapeutics ROERockwell Medical ROEContext Therapeutics operating marginRockwell Medical operating marginContext Therapeutics revenue growthRockwell Medical revenue growthContext Therapeutics free cash flowRockwell Medical free cash flow
Context Therapeutics & Rockwell Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.